rs568556987
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003119.4(SPG7):c.1937-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,330 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003119.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPG7 | NM_003119.4 | c.1937-2A>G | splice_acceptor_variant, intron_variant | Intron 14 of 16 | ENST00000645818.2 | NP_003110.1 | ||
SPG7 | NM_001363850.1 | c.1937-2A>G | splice_acceptor_variant, intron_variant | Intron 14 of 17 | NP_001350779.1 | |||
SPG7 | XM_047434537.1 | c.1064-2A>G | splice_acceptor_variant, intron_variant | Intron 9 of 12 | XP_047290493.1 | |||
SPG7 | XM_047434540.1 | c.623-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 8 | XP_047290496.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250482Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135692
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461032Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 726830
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74472
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 7 Pathogenic:1
This sequence change affects an acceptor splice site in intron 14 of the SPG7 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs568556987, ExAC 0.02%). Disruption of this splice site has been observed in combination with another SPG7 variant in individuals with clinical features of hereditary spastic paraplegia and to segregate with disease in a family (PMID: 22964162, 30533525). ClinVar contains an entry for this variant (Variation ID: 465174). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SPG7 are known to be pathogenic (PMID: 21623769, 22964162). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
This variant is expected to severely impact normal RNA splicing, and consequently, protein structure and/or function. The frequency of this variant in the general population is consistent with pathogenicity. (http://gnomad.broadinstitute.org) This variant has been identified in at least one individual with clinical features associated with this gene. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at